Collegium Pharmaceutical Doubles Down on ADHD With $650M AZSTARYS Acquisition

While macro headlines continue to dominate investor attention, small-cap specialty pharma company Collegium Pharmaceutical (NASDAQ: COLL) is quietly executing a disciplined growth strategy — and its latest move is hard to ignore.

The Stoughton, Massachusetts-based company announced a definitive agreement to acquire AZSTARYS, an FDA-approved ADHD treatment, from privately held Corium Therapeutics for $650 million in cash at closing, with the potential for up to $135 million in additional milestone payments tied to future commercial and regulatory targets. The deal is expected to close in the second quarter of 2026.

What Is AZSTARYS and Why Does It Matter?

AZSTARYS is a central nervous system stimulant combining immediate-release and long-acting components in a single capsule, approved for patients aged six and older with Attention Deficit Hyperactivity Disorder. It is one of the more differentiated products in the ADHD space precisely because of that dual-mechanism delivery — something that sets it apart from a crowded field of single-mechanism competitors.

The commercial traction is already there. AZSTARYS generated more than 760,000 prescriptions in 2025, and Collegium projects the drug will contribute over $50 million in pro forma net revenue in just the second half of 2026 — assuming the deal closes on schedule. Six Orange Book-listed patents, most of which do not expire until December 2037, provide long-runway exclusivity that gives this asset real staying power on Collegium’s balance sheet.

Collegium already markets Jornay PM, a delayed-release methylphenidate treatment for ADHD. Adding AZSTARYS gives the company two commercially differentiated products targeting the same condition but with distinct dosing profiles — a smart way to expand market penetration without cannibalizing existing revenue.

The deal structure reflects that discipline. Collegium plans to fund the acquisition using cash on hand and a previously arranged $300 million delayed-draw term loan, with management projecting post-close net leverage of approximately two times estimated 2026 combined adjusted EBITDA. Run-rate cost synergies are expected to exceed $50 million within twelve months of closing, driven by Collegium leveraging its existing ADHD commercial infrastructure rather than building a parallel one from scratch.

The transaction has been unanimously approved by the boards of both companies and is subject to customary regulatory approvals, including Hart-Scott-Rodino clearance.

At a market cap of approximately $1.15 billion, Collegium is doing something many larger companies struggle with — making acquisitions that are both strategically coherent and financially disciplined. The AZSTARYS deal is not a moonshot. It is a calculated bet on a proven, revenue-generating asset with durable patent protection in a therapeutic category — ADHD — that continues to see strong and growing demand across both pediatric and adult patient populations.

Needham & Company reaffirmed its Buy rating on COLL this week with a price target of $56, representing meaningful upside from the stock’s current trading range near $36. The broader analyst consensus sits at Buy, though the stock has traded down from its 52-week high near $51 amid broader market volatility.

For investors focused on the small and microcap space, Collegium’s approach offers a case study in how companies under $2 billion in market cap can use M&A not as a hail mary, but as a precision tool for compounding long-term value.

New Home Sales Hit Four-Year Low

New home sales rang in 2026 with a troubling signal. January sales of newly built homes collapsed 17.6% month over month to a seasonally adjusted annualized rate of 587,000 units — the slowest pace since 2022 — according to data released Thursday by the U.S. Census Bureau. The drop was far steeper than analysts had projected, and it arrived against a backdrop that was supposed to be improving.

Year over year, sales were down 11.3%, with December’s already-soft numbers revised even lower. For homebuilders — many of them small and mid-cap companies already managing tight margins and bloated inventory — the report adds urgency to a housing sector that has yet to find solid footing.

The January data reflects signed contracts from a period when the average 30-year fixed mortgage rate was hovering between 6% and 6.2%, according to Mortgage News Daily. Rates have since climbed to 6.36%, meaning conditions in the months ahead are unlikely to produce a meaningful rebound without a catalyst. The Federal Reserve’s decision Wednesday to hold rates steady at 3.5%–3.75% — with the dot plot pointing to just one cut in 2026 — offers little relief for rate-sensitive buyers sitting on the sidelines.

To move inventory, builders have been reaching deeper into their toolkits. The median price of a new home sold in January fell to $400,500, a decline of 6.8% year over year. Yet the discounts aren’t clearing the market fast enough. Inventory climbed to a 9.7-month supply, up from eight months in December and 7.8% higher than a year ago. Completed homes sitting unsold are now near levels not seen since 2009.

The pain is spreading into March. An estimated 37% of builders cut prices in March, up from 36% in February, according to the National Association of Home Builders. Nearly two-thirds of builders are deploying additional incentives including mortgage rate buydowns to pull buyers across the finish line — a strategy that protects top-line revenue while quietly compressing margins.

Sales declined across every region, but the drops were not equal. The Northeast and Midwest could partially blame harsh winter weather. The West has no such excuse — sales there fell nearly 22% from December, suggesting demand destruction that runs deeper than seasonal disruption. Sun Belt markets, after years of speculative overbuilding, continue to be among the hardest hit.

For investors tracking small and mid-cap homebuilders, the January report is a reminder that volume recovery and margin recovery are not the same story. Companies relying heavily on incentive-driven sales risk deteriorating earnings quality even as unit counts look stable. With the Fed on hold, mortgage rates sticky above 6%, and consumer confidence still fragile, the setup for the spring selling season — typically the industry’s most critical window — looks challenged at best.

The pent-up demand is real. The question is whether affordability conditions improve fast enough to release it before builder balance sheets feel the weight.

Perfect (PERF) – Founder-Led Take-Private Proposal


Thursday, March 19, 2026

Patrick McCann, CFA, Research Analyst, Noble Capital Markets, Inc.

Michael Kupinski, Director of Research, Equity Research Analyst, Digital, Media & Technology , Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Take Private Proposal. Perfect Corp. received a preliminary, non-binding proposal from a consortium led by CEO Alice H. Chang and CyberLink to take the company private at $1.95 per share. The transaction would be funded through rollover equity, company cash, and potential debt. The board intends to form a special committee to evaluate the proposal, and there is no assurance that a transaction will be completed.

Ownership structure supports a high likelihood of completion. The consortium controls approximately 53.4% of shares and 81.2% of voting power. In our view, this significantly increases the likelihood of a transaction, subject to special committee approval.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Star Equity Holdings, Inc. (STRR) – Fourth Quarter 2025 Results


Thursday, March 19, 2026

Joe Gomes, CFA, Managing Director, Equity Research Analyst, Generalist , Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Overview. Star Equity’s fourth quarter and full-year financial results reflect positive momentum and improvement over the prior year quarter, largely driven by the August 2025 merger. Overall, 2025 was a transformational year for Star. The merger strengthened the Company’s operating and financial position and accelerated the growth strategy.

4Q25 Results. Fourth quarter 2025 revenue of $56.8 million rose 69% y-o-y, but was slightly below our $58 million estimate. Adjusted EBITDA increased to $2.2 million versus $0.9 million last year. We had projected $2.3 million. Adjusted net loss was $0.10/sh, compared to adjusted net income of $0.04/sh in 4Q24.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

SelectQuote (SLQT) – Launching Franchise-Based Distribution Channel


Thursday, March 19, 2026

Patrick McCann, CFA, Research Analyst, Noble Capital Markets, Inc.

Michael Kupinski, Director of Research, Equity Research Analyst, Digital, Media & Technology , Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

SelectQuote Local. SelectQuote announced SelectQuote Local, a new franchise model designed to complement its core telephonic insurance distribution platform by offering in-person sales and support. Management indicated the initiative leverages the company’s existing marketing, technology, and carrier relationships, positioning it as a natural extension of the platform rather than a shift in strategy.

Complementary model and TAM expansion. In our view, SelectQuote Local is unlikely to cannibalize the company’s core call center operations, as it targets a distinct subset of consumers who prefer in-person engagement. We believe the company can leverage excess lead flow and brand recognition to support early franchise success without significant incremental marketing investment. Additionally, we expect the in-person model could enhance cross-sell opportunities with Healthcare Services, as local relationships may improve customer engagement and trust.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Kuya Silver (KUYAF) – Driving Mineral Resource Growth


Thursday, March 19, 2026

Mark Reichman, Managing Director, Equity Research Analyst, Natural Resources, Noble Capital Markets, Inc.

Hans Baldau, Associate Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Kuya Silver is significantly scaling its exploration efforts at Bethania. The company has expanded its fully funded 2026 drill program to approximately 20,000 meters, making it the largest drilling campaign in the project’s history. By combining 10,000 meters of surface and 10,000 meters of underground drilling, Kuya seeks to extend known mineralization near existing operations and test new district scale targets, positioning the project for meaningful resource growth.

High-grade regional targets highlight strong expansion potential. Exploration has identified multiple vein systems beyond the current mine area, with high priority prospects such as Millococha, Tito PH, and Carmelitas demonstrating encouraging grades and geological continuity. These areas, supported by historic artisanal mining and recent sampling, suggest the presence of a broader mineralized system that could materially increase the overall resource base.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

The End of Quarterly Earnings? What the SEC’s Reporting Overhaul Means for Small Caps

A regulatory change decades in the making may finally be approaching — and for small and microcap public companies, the implications could be significant.

The Securities and Exchange Commission is preparing a proposal that would make quarterly earnings reporting optional, allowing public companies to instead report financial results twice per year. The proposal, which could be published as early as April, is currently in discussions between the SEC and major stock exchanges regarding how listing rules would need to adjust. Once published, it will enter a public comment period of at least 30 days before the SEC votes on the rule.

SEC Chairman Paul Atkins and President Donald Trump have both voiced support for the shift. Trump first raised the idea during his first term in 2018, arguing that semiannual reporting would reduce short-term thinking and cut the administrative costs burdening public companies. That argument has only gained traction since. The quarterly treadmill — preparing financial statements, coordinating with auditors, hosting earnings calls — runs on a near-constant cycle for CFOs at small public companies, consuming resources that lean teams at microcap firms can ill afford.

For larger companies with dedicated investor relations departments and deep finance teams, quarterly reporting is manageable. For a $200 million market cap company with 50 employees, it can feel like a full-time job. Supporters of the proposed change argue this compliance burden is one of the key reasons why many companies choose to stay private longer — or simply never go public at all. A semiannual reporting structure could lower the bar to entry for the public markets and broaden the investable universe of small and microcap stocks.

The EU and the UK both moved to semiannual mandatory reporting roughly a decade ago. Notably, many companies in both markets continued reporting quarterly by choice — suggesting the market itself can enforce disclosure standards even without a regulatory mandate. That precedent is likely to be a central argument for U.S. adoption.

The opposition is real, however. Critics argue that less frequent disclosures reduce market transparency, create wider informational gaps between company insiders and retail investors, and could increase volatility around the two annual reporting windows. For microcap stocks — where information asymmetry is already higher and trading volumes are lower — a six-month gap between financial updates raises legitimate concerns about price discovery.

There’s also the question of what “optional” really means in practice. Institutional investors and analysts who cover microcap names expect regular data. Companies that choose semiannual reporting may find themselves at a disadvantage in terms of analyst coverage and institutional interest, particularly if peers in the same sector continue reporting quarterly. In other words, the market may continue enforcing the quarterly standard even if the SEC doesn’t.

What’s clear is that this proposal has direct implications for the small and microcap space — more so than for any other segment of the public markets. The cost-benefit calculation is most acute at smaller companies, and the potential to attract more issuers to the public markets is a legitimate upside worth monitoring.

The SEC’s formal proposal is expected to follow soon. For issuers, investors, and advisors in the small and microcap space, the comment period will be the time to shape what this change actually looks like in practice.

Federal Reserve Holds Rates Steady in March 2026 — One Cut Still on the Table as Economy Shows Resilience

The Federal Reserve held its benchmark interest rate unchanged Wednesday, keeping the federal funds rate in the range of 3.5% to 3.75% as policymakers assess a shifting economic landscape shaped by elevated energy prices, a resilient growth outlook, and ongoing uncertainty tied to the conflict in the Middle East. The decision marks the second consecutive hold this year, with officials maintaining their projection of one rate cut in 2026 — consistent with guidance issued in December.

The vote was split. Fed Governor Stephen Miran dissented in favor of an immediate quarter-point reduction, reflecting the diversity of views inside the central bank as policymakers weigh competing signals from inflation data, labor markets, and geopolitical developments.

For the first time, the Fed formally acknowledged the war in Iran as an economic variable, stating that “the implications of developments in the Middle East for the U.S. economy are uncertain.” The acknowledgment signals that policymakers are actively monitoring the conflict’s impact on energy prices and supply chains as they assess the timing and pace of future policy adjustments.

Inflation forecasts were revised modestly higher as a result. Officials now see headline inflation at 2.7% for 2026, up from a prior estimate of 2.4%, and core inflation — which excludes food and energy — at 2.7% versus the previous 2.5% projection. While inflation remains above the Fed’s 2% target, the central bank’s updated projections also reflect a more optimistic view of overall economic growth, suggesting policymakers see the current environment as manageable rather than alarming.

In a constructive revision, the Fed raised its GDP growth forecast to 2.4% for 2026, up from 2.3% previously, reflecting continued economic momentum. The unemployment rate projection held steady at 4.4% — a level historically consistent with a healthy labor market.

Month-to-month payroll data has been choppy — January posted a gain of 126,000 jobs followed by a decline of 92,000 in February — but the unemployment rate has remained largely stable throughout the swing, which Fed officials noted as a point of continuity. Policymakers are watching incoming data closely before drawing conclusions about the labor market’s direction.

The Fed’s steady-hand approach offers a degree of predictability that markets and businesses can plan around. With one rate cut still projected for 2026, the path toward monetary easing remains intact — even if the timeline is data-dependent. For small and microcap companies, the key takeaway is that the cost of capital environment, while elevated, appears to be stabilizing rather than tightening further.

The breadth of opinion inside the Fed — ranging from no cuts to as many as four this year — reflects genuine debate rather than consensus pessimism, and leaves room for the policy outlook to shift as energy markets and labor data evolve through the year.

Adding another dimension to the Fed’s near-term story: Chair Jerome Powell’s term expires May 15, and his nominated successor Kevin Warsh awaits Senate confirmation. The transition is unfolding against a complex political backdrop, but the Fed’s institutional framework and data-driven decision-making process are expected to remain intact regardless of timing.

The direction of travel on rates is still lower. The question is when.

Trump Waives the Jones Act: A Bold Bet to Cool Surging Oil and Gas Prices

President Trump issued a 60-day waiver of the Jones Act on Wednesday in a bid to cool surging domestic energy prices as the Iran conflict continues to hammer global oil markets. The move, confirmed by White House press secretary Karoline Leavitt, opens U.S. ports to foreign-flagged vessels for the next two months — covering crude oil, refined products like gasoline and diesel, natural gas, coal, fertilizer, and other energy-derived commodities.

The decision comes as Brent crude crossed $109 per barrel Wednesday morning — up more than 7% on the day — while WTI traded above $97. Gas prices at the pump have climbed to a national average of $3.84 per gallon, up sharply from $2.92 just one month ago, according to AAA data. Diesel has already crossed $5 per gallon nationally. The administration is clearly feeling political pressure to act ahead of the midterm cycle, and the Jones Act waiver is the most tangible move it has made so far.

What the Jones Act Actually Does

The Jones Act — formally the Merchant Marine Act of 1920 — requires that any cargo transported between U.S. ports be carried by vessels that are U.S.-built, U.S.-owned, U.S.-flagged, and U.S.-crewed. The law was designed to protect the domestic shipping industry after World War I, but has long been criticized by economists as an inflationary form of protectionism that raises the cost of moving goods within the country. With fewer than 100 Jones Act-compliant vessels in existence, the waiver immediately opens the door to a much larger pool of international tankers to move fuel between domestic ports.

The Practical Impact — And Its Limits

In theory, the waiver should have its biggest effect on refined product shipments from Gulf Coast refinery complexes to the more isolated East Coast — a corridor that has historically been a bottleneck during supply disruptions. Cheaper, more accessible shipping capacity means fuel can theoretically move faster and at lower cost to the regions that need it most.

But experts are already tempering expectations. The core problem isn’t moving fuel — it’s refining it. Most U.S. refineries are configured to process heavier Middle Eastern crude grades, while domestic shale production yields lighter oil. That structural mismatch means the U.S. still cannot fully self-supply even with more flexible shipping rules. The waiver makes domestic logistics more efficient, but it does not solve the underlying supply equation.

The Broader Policy Picture

The Jones Act move is reportedly just one item on a broader White House menu of potential energy interventions being considered, including possible Treasury-led action in energy futures markets and export bans on crude and refined products. Any of those measures — if enacted — would carry significant market implications across the energy sector.

For small and microcap investors, the read-through is layered. Domestic shippers and Jones Act operators could see near-term pricing pressure as foreign competition enters the market. Refiners with Gulf Coast exposure and East Coast distribution capability may benefit from improved logistics economics. And any company with meaningful fuel cost exposure — from regional truckers to agricultural operators to industrial manufacturers — should be watching this space closely as the administration continues to improvise policy responses to a crisis with no clear end date.

The 60-day clock starts now.

Gyre Therapeutics, Inc (GYRE) – Priority Review Received For Hydronidone In China


Wednesday, March 18, 2026

Robert LeBoyer, Senior Vice President, Equity Research Analyst, Biotechnology, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Gyre Receives Priority Review. Hydronidone has been awarded Priority Review Status by the Center for Drug Evaluation (CDE) of China’s National Medical Products Administration (NMPA). This is consistent with our expectations for an accelerated NDA review and late FY2026 approval for Hydronidone.

Meeting With The CMPA Was Positive. In early January, Gyre Pharmaceuticals (China) held a Pre-New Drug Application meeting with the CDE. At that time, the CDE agreed that data from the Hydronidone Phase 3 trial for treating chronic hepatitis B (CHB)-associated liver-fibrosis supported an application for conditional approval. It also met the criteria for Priority Review.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Greenwich LifeSciences, Inc. (GLSI) – Preliminary Phase 3 FLAMINGO-01 Update Shows Reduction In Breast Cancer Recurrence Rate


Wednesday, March 18, 2026

Robert LeBoyer, Senior Vice President, Equity Research Analyst, Biotechnology, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

New Analysis Shows Less Than 1% Recurrance Rate. Greenwich Pharmaceuticals announced a preliminary update from its FLAMINGO-01 trial. The data from the open-label arm of the trial showed a recurrence rate of less than 1% per year compared to a recurrence rate of 4% per year for patients treated with Kadcyla (ado-trastuzumab emtansine or T-DM1, from Genentech) in the Phase 3 KATHERINE Study. This is a 70% to 80% reduction in the historical recurrence rate for these patients.

Background On The Phase 3 FLAMINGO-01 Trial. The trial tests GLSI-100, an immunotherapy to prevent recurrence of  HER2-positive breast cancer. Its design has a double-blind portion that enrolls patients with the immune marker HLA-A*02 to receive either GLSI-100 or placebo, and an open-label arm that enrolls patients that have other HLA types (non-HLA-A*02). The new data is from the open-label arm of the trial.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Summit Midstream Corp (SMC) – Double E Pipeline Underpins Favorable Growth Outlook


Wednesday, March 18, 2026

Mark Reichman, Managing Director, Equity Research Analyst, Natural Resources, Noble Capital Markets, Inc.

Hans Baldau, Associate Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Double E Pipeline growth. Summit recently signed two new long-term take-or-pay agreements totaling 540 MMcf/d of incremental firm capacity on the Double E Pipeline, an 11-year, 210 MMcf/d contract with a large investment-grade shipper and an 11-year, 230 MMcf/d agreement with an undisclosed shipper, alongside the previously announced 100 MMcf/d Producers Midstream II commitment, which received an affirmative FID during the quarter. These contracts are expected to grow the Permian Segment Adj. EBITDA from ~$34 million in 2025 to ~$60 million by 2029.

2026 guidance. Summit expects full-year 2026 Adj. EBITDA of $225 million to $265 million, with total capital expenditures of $85 million to $105 million, including approximately $35 million attributable to Double E. The outlook assumes WTI at approximately $64 per barrel and Henry Hub at approximately $3.40 per MMBtu, both materially below current strip prices, suggesting meaningful upside if the commodity environment is sustained. The company expects 116 to 126 well connections supported by seven active rigs and approximately 90 DUCs.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Snail (SNAL) – Quarterly Preview: Strategic Updates Provided At GDC


Wednesday, March 18, 2026

Snail is a leading, global independent developer and publisher of interactive digital entertainment for consumers around the world, with a premier portfolio of premium games designed for use on a variety of platforms, including consoles, PCs and mobile devices.

Michael Kupinski, Director of Research, Equity Research Analyst, Digital, Media & Technology , Noble Capital Markets, Inc.

Jacob Mutchler, Research Associate, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Strategic updates ahead of Q4 Earnings Call. At the Game Developers Conference (GDC) in San Francisco last week, the company provided updates across its game portfolio, outlining a steady pipeline of ARK franchise releases, expansions for existing titles, and new indie projects. The announcements were delivered ahead of the company’s Q4 and full-year 2025 earnings call scheduled for March 19, 2026, at 4:30 p.m. ET, providing a preview of its strategic product developments.

Strong Early Access sales. Notably, Bellwright has surpassed 1 million units sold on Steam during Early Access, demonstrating strong player engagement ahead of its 1.0 launch and planned expansion to Xbox and PlayStation. As a reminder, development is now fully in-house following the acquisition and integration of Donkey Crew, the Poland-based studio behind Bellwright, strengthening the franchise’s long-term potential.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision.